journal article·2020-01-28Open access

Trans-Cyclooctene-Functionalized PeptoBrushes with Improved Reaction Kinetics of the Tetrazine Ligation for Pretargeted Nuclear Imaging

E. Johanna L. Stéen, Jesper T. Jørgensen, Kerstin Johann, Kamilla Nørregaard, Barbara Sohr, Dennis Svatunek, Alexander Birke, Vladimir Shalgunov, Patricia E. Edem, Raffaella Rossin, Christine Seidl, Friederike Schmid, Marc S. Robillard, Jesper L. Kristensen, Hannes Mikula, Matthias Barz, Andreas Kjær, Matthias M. Herth

ACS Nano· Volume 14· Issue 1

Abstract

In-labeled imaging agent is a 1,2,4,5-tetrazine derivative, which can react with aforementioned TCO-modified PeptoBrushes in a rapid bioorthogonal ligation. A high degree of TCO loading (up to 30%) was achieved, without altering the physicochemical properties of the polymeric nanoparticle. The highest degree of TCO loading resulted in significantly increased reaction rates (77-fold enhancement) compared to those with small molecule TCO moieties when using lipophilic tetrazines. Based on computer simulations, we hypothesize that this increase is a result of hydrophobic effects and significant rearrangements within the polymer framework, in which hydrophobic patches of TCO moieties are formed. These patches attract lipophilic tetrazines, leading to increased reaction rates in the bioorthogonal ligation. The most reactive system was evaluated as a targeting agent for pretargeted imaging in tumor-bearing mice. After the setup was optimized, sufficient tumor-to-background ratios were achieved as early as 2 h after administration of the tetrazine imaging agent, which further improved at 22 h, enabling clear visualization of CT-26 tumors. These findings show the potential of PeptoBrushes to be used as a pretargeting agent when an optimized dose of polymer is used.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Click Chemistry and Applications · Chemical Synthesis and Analysis · Monoclonal and Polyclonal Antibodies Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark

Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark

Cluster for Molecular Imaging, Department of Biomedical Sciences, University of Copenhagen, Blegdamsvej 3, 2100 Copenhagen Ø, Denmark

Institute of Organic Chemistry, Johannes Gutenberg University, Duesbergweg 10-14, D-55099 Mainz, Germany

Institute of Applied Synthetic Chemistry, Technische Universität Wien (TU Wien), Getreidemarkt 9, 1060 Vienna, Austria

Tagworks Pharmaceuticals, Geert Grooteplein 10, 6525 GA Nijmegen, The Netherlands

Institute of Physics, Johannes Gutenberg University, Staudingerweg 7-9, D-55099 Mainz, Germany

Funding

Natur og Univers, Det Frie Forskningsr?d · Deutsche Forschungsgemeinschaft · Novo Nordisk Fonden · Max-Planck-Gesellschaft · H2020 Health · Innovationsfonden · H2020 European Research Council · Lundbeckfonden

References (59)

Show source-provided references
1. 10.1038/nrc.2016.10810.1038/nrc.2016.108 ↗
2. 10.1016/j.jconrel.2011.09.06310.1016/j.jconrel.2011.09.063 ↗
3. Matsumura Y. · Cancer Res. · 1986 · 46 · 6387
4. 10.1016/j.canlet.2006.06.00710.1016/j.canlet.2006.06.007 ↗
5. 10.1016/j.addr.2010.04.00910.1016/j.addr.2010.04.009 ↗
6. 10.1038/nrc.2017.9310.1038/nrc.2017.93 ↗
7. 10.1158/1078-0432.CCR-16-319310.1158/1078-0432.CCR-16-3193 ↗
8. 10.1016/j.jconrel.2017.06.01110.1016/j.jconrel.2017.06.011 ↗
9. 10.1038/ncomms1183810.1038/ncomms11838 ↗
10. 10.1158/1078-0432.CCR-16-199010.1158/1078-0432.CCR-16-1990 ↗
11. Harrington K. J. · Clin. Cancer Res. · 2001 · 7 · 243
12. 10.1007/s00280-014-2477-x10.1007/s00280-014-2477-x ↗
13. 10.1021/mp100365210.1021/mp1003652 ↗
14. 10.1021/bc800299f10.1021/bc800299f ↗
15. 10.1007/s00259010062810.1007/s002590100628 ↗
16. 10.2967/jnumed.109.06586210.2967/jnumed.109.065862 ↗
17. 10.1007/s00259-014-2713-y10.1007/s00259-014-2713-y ↗
18. 10.1038/316265a010.1038/316265a0 ↗
19. 10.1097/00006231-198608000-0000210.1097/00006231-198608000-00002 ↗
20. 10.1016/j.biomaterials.2018.06.02110.1016/j.biomaterials.2018.06.021 ↗
21. 10.1016/j.cbpa.2003.08.00610.1016/j.cbpa.2003.08.006 ↗
22. 10.1021/ja805380510.1021/ja8053805 ↗
23. 10.1039/C4SC01348D10.1039/C4SC01348D ↗
24. 10.1039/c3cc41027g10.1039/c3cc41027g ↗
25. 10.1016/j.bmcl.2019.02.01410.1016/j.bmcl.2019.02.014 ↗
26. 10.1186/s13550-019-0520-y10.1186/s13550-019-0520-y ↗
27. 10.1002/anie.20090629410.1002/anie.200906294 ↗
28. 10.2967/jnumed.112.11584010.2967/jnumed.112.115840 ↗
29. 10.1021/acs.molpharmaceut.5b0029410.1021/acs.molpharmaceut.5b00294 ↗
30. 10.1021/acs.bioconjchem.5b0050410.1021/acs.bioconjchem.5b00504 ↗
31. 10.1021/acs.jmedchem.7b0110810.1021/acs.jmedchem.7b01108 ↗
32. 10.1186/s13550-017-0344-610.1186/s13550-017-0344-6 ↗
33. 10.1007/s10875-016-0265-610.1007/s10875-016-0265-6 ↗
34. 10.1021/bc500498210.1021/bc5004982 ↗
35. 10.1021/acsnano.5b0686010.1021/acsnano.5b06860 ↗
36. 10.1021/mp500275a10.1021/mp500275a ↗
37. 10.1021/bc400153y10.1021/bc400153y ↗
38. 10.1021/bm401542z10.1021/bm401542z ↗
39. 10.1021/ma502497x10.1021/ma502497x ↗
40. 10.1002/marc.20150040310.1002/marc.201500403 ↗
41. 10.1002/anie.20170262410.1002/anie.201702624 ↗
42. 10.1002/pola.2668710.1002/pola.26687 ↗
43. 10.1021/bc700166510.1021/bc7001665 ↗
44. 10.1021/acsnano.8b0443310.1021/acsnano.8b04433 ↗
45. 10.1515/zpch-1918-920910.1515/zpch-1918-9209 ↗
46. 10.1002/anie.20140389010.1002/anie.201403890 ↗
47. 10.1021/acs.bioconjchem.6b0023410.1021/acs.bioconjchem.6b00234 ↗
48. 10.1021/jm00378a02110.1021/jm00378a021 ↗
49. Strobl G. · 2007
50. 10.1016/0263-7855(96)00018-510.1016/0263-7855(96)00018-5 ↗
51. 10.1016/j.biomaterials.2016.05.00310.1016/j.biomaterials.2016.05.003 ↗
52. 10.1021/nl404391r10.1021/nl404391r ↗
53. 10.1038/natrevmats.2016.1410.1038/natrevmats.2016.14 ↗
54. 10.2967/jnumed.113.12374510.2967/jnumed.113.123745 ↗
55. 10.1016/j.tetlet.2014.07.01210.1016/j.tetlet.2014.07.012 ↗
56. 10.1002/anie.20130596910.1002/anie.201305969 ↗
57. 10.1039/c3py00347g10.1039/c3py00347g ↗
58. 10.1021/acs.macromol.8b0025810.1021/acs.macromol.8b00258 ↗
59. 10.1016/S0040-4039(99)00968-510.1016/S0040-4039(99)00968-5 ↗